Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci
Pharmacogenomics J. 2024 Jun 29;24(4):21. doi: 10.1038/s41397-024-00343-0. ABSTRACT There is a known genetic susceptibility to anthracycline-induced cardiac dysfunction in childhood cancer survivors, but this has …